The Global Connected Drug Delivery Devices Market Size was worth around USD 7.34 billion in 2024 and is predicted to grow to around USD 72.54 billion by 2035 with a compound annual growth rate (CAGR) of 23.15 % from 2025 to 2035.
The medical devices with digital connectivity and communication capabilities that allow for tracking, monitoring, and managing medication administration are referred to as connected drug delivery devices. Connectivity to a variety of digital services is one of the fundamental features of connected medication delivery devices. In addition, the technology that improves patient adherence, improves treatment outcomes, and gives medical personnel precise data for individualised care is provided by these medical devices. Many market players are working on these devices in a bid to provide better monitoring of patients and counselling.
This comprehensive market research report provides an in-depth analysis of the Connected Drug Delivery Devices market, with a focused evaluation of industry developments through 2025. The study delivers detailed insights into current market dynamics, emerging trends, growth drivers, competitive landscape, future strategic outlook, and the evolving regulatory key segments.
The Global Connected Drug Delivery Devices Market Report identifies emerging business opportunities while supporting informed strategic and tactical decision-making. Designed for stakeholders operating in a highly competitive and rapidly evolving landscape, this study delivers up-to-date market intelligence essential for tracking performance, mitigating risks, and driving sustainable growth and profitability.
Our expert team is consistently working on updated data and information on the key player's related business processes that value the market for future strategies and predictions
Get Access to a Free Copy of Our Latest Sample Report - https://www.decisionsadvisors.com/request-sample/DAR4492
Market Segmentation:
By Type
- Injectable Devices
- Inhalation Devices
- Others
By Technology
- Bluetooth
- NFC
- Others
Key Players Detail:
In-depth competitive benchmarking analysis of the Connected Drug Delivery Devices Market, covering company market share, innovation strategies, product development, geographic expansion, and strategic partnerships shaping the industry landscape.
- Adherium
- Aptar Pharma
- AstraZeneca
- Becton, Dickinson, and Company
- Bigfoot Biomedical
- Cohero Health
- Eli Lilly and Company
- Insulet Corporation
- Novartis
- Novo Nordisk
- Phillips Medisize
- Propeller Health
- Teva Pharmaceuticals
- West Pharmaceutical Services
- Others
Key Insights Covered in the Global Connected Drug Delivery Devices Market Size & Industry Forecast Report (2020–2035):
1. Detailed analysis of the Global Connected Drug Delivery Devices Market Size, production capacity, utilization rate, output trends, capital investment patterns, and regulatory landscape, along with comprehensive profiles of leading market players.
2. Thorough assessment of Connected Drug Delivery Devices Market Growth, revenue analysis, historical performance, and forward-looking projections across major regional markets.
3. In-depth Connected Drug Delivery Devices Industry Analysis covering competitive landscape, company market share, pricing trends, and future opportunity mapping.
4. Strategic evaluation of recent developments including mergers & acquisitions, partnerships, collaborations, joint ventures, geographic expansions, and product launches shaping the Connected Drug Delivery Devices Market Share.
5. Comprehensive value chain and supply chain analysis highlighting raw material sourcing, distribution channels, and end-user segmentation.
6. Regional regulatory framework assessment and policy impact analysis influencing the Connected Drug Delivery Devices Industry Forecast across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
7. Coverage of technological advancements, product innovations, R&D investments, automation trends, and digital transformation influencing long-term Global Connected Drug Delivery Devices Market Growth.
Buy this report now:- https://www.decisionsadvisors.com/checkout/select-licence?report_id=DAR4492
Industry Developments:
In February 2026, Medtronic officially launched the MiniMed Go Smart MDI system with the Simplera sensor across Europe. This marks the first integrated solution that combines data from the InPen smart insulin pen and the Simplera™ continuous glucose sensor into a single mobile app. The system provides real-time, actionable insights for people managing diabetes with multiple daily injections (MDI), helping improve glucose control and treatment decisions.
In October 2025, BD (Becton, Dickinson and Company) launched new AI-enabled solutions to strengthen connectivity across healthcare settings. At the core is the BD Incada Connected Care Platform, a scalable, cloud-based ecosystem that unifies data from BD devices, including infusion pumps, patient monitors, and pharmacy robotics, into one intelligent network. The platform debuted alongside the next-generation BD Pyxis Pro Automated Medication Dispensing Solution, enabling enterprise-wide visibility and actionable insights.
Regional Analysis for Connected Drug Delivery Devices Market:
✫ North America: (U.S., Canada, Mexico)
✫ Europe: (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
✫ Asia-Pacific: (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
✫ South America: (Colombia, Brazil, Argentina, Rest of South America)
✫ Middle East & Africa: (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
⏩ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
⏩ Top-down and bottom-up approach for regional analysis
⏩ Porter’s five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
⏩ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Insightful inquiry before buying:- https://www.decisionsadvisors.com/request-customization/DAR4492
Frequently asked questions:
➥ What is the market size of the Connected Drug Delivery Devices market?
➥ What is the market growth rate of the Connected Drug Delivery Devices market?
➥ What are the Connected Drug Delivery Devices market opportunities and threats faced by the vendors in the global Connected Drug Delivery Devices Industry?
➥ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➥ What focused approach and constraints are holding the Connected Drug Delivery Devices market?
➥ What are the different sales, marketing, and distribution channels in the global industry?
Unlock the full report now! @ https://www.decisionsadvisors.com/reports/connected-drug-delivery-devices-market
About the Decisions Advisors
Decisions Advisors is a comprehensive market research and consulting company that provides actionable insights based on data. We deal with businesses from various industries and deliver a market intelligence, competitive analysis, forecasting, and bespoke consulting. We also conduct bespoke consulting for our clients.
We provides well-supported advice and intelligence on how businesses can operate in a given market and succeed in achieving their goals.
Contact Us:
Company Name: Decision Advisors
Email: sales@sphericalinsights.com
Phone: +1 303 800 4326 (US)
